MedPath

The Gratitude Gallery - A Positive Psychology Intervention

Not Applicable
Completed
Conditions
Anxiety
Depression
Interventions
Behavioral: taking photographs
Registration Number
NCT04723251
Lead Sponsor
University of Michigan
Brief Summary

This study will assess the feasibility and acceptability of a positive psychology intervention, The Gratitude Gallery, for increasing gratitude in adults.

The study hypothesizes that participants will find the activity feasible and acceptable and complete the intervention as directed. The project also hypothesizes that those that complete the intervention will show an increase in self-reported gratitude, as well as a decrease in symptoms of anxiety and depression.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • Able to read/understand English and give consent
  • Owns a smart phone capable of taking pictures
  • Willing and able to comply with all aspects of study procedures
  • PHQ-9 score greater or equal to 5 but less or equal to 14 with no suicidal ideation
  • Generalized anxiety disorder (GAD-7) score greater or equal to 0 but less or equal to 9
  • No plan to initiate a new program that could increase positive affect during the study period (e.g., psychotherapy, new exercise regimen, meditation classes)
  • If on medication then stable (at least 3 months) on dose or not on medication
Read More
Exclusion Criteria
  • Having a psychotic disorder active suicidality or severe depressive or anxiety symptoms
  • Other factors that at the discretion of the investigators that would adversely affect study participation
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Taking Photographstaking photographsParticipants will be asked to take photos with their cell phone.
Primary Outcome Measures
NameTimeMethod
Acceptability of the The Gratitude Gallery2 years

Number of participants that are eligible for the study compared to the number of patients that are enrolled. The higher the ratio of participants enrolled the higher acceptability.

Changes in the level of reported gratitude as measured by the Gratitude Questionnaire - 6 (GQ-6).Baseline, up to day 60

This is a six question, self-reported survey designed to assess individual differences in the proneness to experience gratitude in daily life. The GQ-6 uses a 7-point Likert scale with responses that range from "strongly disagree" to "strongly agree". Questions 3 and 6 are reverse scored. A higher total score indicated higher levels of gratitude.

Feasibility of the The Gratitude Galleryup to 21 days (days of treatment)

Participants that complete 15 of the 21 intervention days will be considered to be feasible.

Secondary Outcome Measures
NameTimeMethod
Changes in depressive symptoms using the Patient Health Questionnaire 9-Item (PHQ-9)Baseline, up to day 60

The PHQ-9 is a brief, self-administered questionnaire that scores each of the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for depression on a scale from 0 to 3. Response options include "not at all", "several days", more than half the days" and "nearly every day". It is a validated measure of depression severity. Scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression, respectively.

Changes in positive and negative affect as measured by the Positive and Negative Affect Scale (PANAS) ScaleBaseline, up to day 60

The PANAS scale is a 20 item mood scale measuring the two primary dimensions of mood. Responses on a 5-point Likert Scale range from "very slightly or not at all" to "extremely". Positive affect and negative affect questions are grouped and scored separately. The PANAS has been shown to be sensitive to short-term fluctuations in mood in addition to showing stability over a longer (2-month) time period.

Changes in General Life Satisfaction - Fixed Form B from the NIH ToolboxBaseline, up to day 60

This is a brief 5-item questionnaire which can be administered to adults over the age of 18. It uses a 7-point Likert scale with responses that range from "strongly disagree" to "strongly agree". The scores for each question are added to create a raw score. This raw score is then converted to a T-score using a conversion table which represents the mean of the United States population.

Changes in sleep quality using the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance - Short Form 4aBaseline, up to day 60

This assessment consists of 4 items which measure sleep quality and sleep disturbances using a 5 point likert scale ranging in value from 1 to 5 with higher scores indicating greater sleep quality.

Changes in anxiety symptoms using the Generalized Anxiety scale (GAD-7)Baseline, up to day 60

The GAD-7 is a self-reported questionnaire that assesses for the seven core symptoms of generalized anxiety disorder and severity. Response options include "not at all", "several days", more than half the days" and "nearly every day". GAD-7 total score for the seven items ranges from 0 to 21. Scores of 5, 10, and 15 represent cut-points for mild, moderate, and severe anxiety, respectively.

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath